New - European Medical Journal

This site is intended for healthcare professionals

Continue

News

Will α-Ketoglutarate Supplementation Pave a New Way for Colorectal Cancer Treatment?
Gastroenterology
14 Apr 2020

Will α-Ketoglutarate Supplementation Pave a New Way for Colorectal Cancer Treatment?

COLORECTAL CANCER predominantly stems from a genetic mutation of APC. In general, a major proportion of people with the mutation…
COVID-19: What You Should Be Aware of As a Gastroenterologist and a Patient
Gastroenterology
14 Apr 2020

COVID-19: What You Should Be Aware of As a Gastroenterologist and a Patient

COVID-19 has spread throughout the word and drastically affected everyday life and clinical practice. Although the disease…
General Healthcare
9 Apr 2020

Predicting an Epidemic? Evolution Must be Considered

SCIENTISTS using mathematical models to predict the spread of disease across populations must consider evolutionary changes…
Linking Clinicians with Suppliers to Address the COVID-19 Medical Equipment Shortag
General Healthcare
6 Apr 2020

Linking Clinicians with Suppliers to Address the COVID-19 Medical Equipment Shortage

EMG-Health is proud to announce the launch of our brand new web-based service connecting clinicians in need of equipment…
Respiratory
6 Apr 2020

Ability to Stabilise and Stockpile Covid-19 Vaccine is Vital

An incredible global effort is underway by companies and scientists digging deep to find a vaccine for Covid-19…
New COVID-19 Vaccine Candidate Generates Neutralising Antibodies
Allergy & Immunology
6 Apr 2020

New COVID-19 Vaccine Candidate Generates Neutralising Antibodies

A VACCINE candidate for COVID-19 has shown promise in mice studies by producing antibodies specific to SARS-CoV-2, at levels thought to be sufficient…
Could Ivermectin be an Effective COVID-19 Treatment?
Respiratory
6 Apr 2020

Could Ivermectin be an Effective COVID-19 Treatment?

IVERMECTIN, an antiparasitic drug that is in use around the world, has shown to kill the SARS-CoV-2 virus within 48 hours…
Rheumatology
2 Apr 2020

Rheumatoid Arthritis Drug to be Repurposed for COVID-19 Therapy in Phase II/III Clinical Trial

The U.S. Department of Human Health and Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR)…
We’ve noticed you’re accessing
from North/South America.